UNLABELLED: In the large community-based Hordaland Health Study, low plasma dimethylglycine was associated with low bone mineral density in both middle-aged and elderly subjects and to an increased risk of subsequent hip fracture among the elderly. These associations seemed to be particularly strong among subjects exposed to nicotine. INTRODUCTION: Dimethylglycine (DMG) is a product of the choline oxidation pathway and formed from betaine during the folate-independent remethylation of homocysteine (Hcy) to methionine. Elevated plasma DMG levels are associated with atherosclerotic cardiovascular disease and inflammation, which in turn are related to osteoporosis. High plasma total Hcy and low plasma choline are associated with low bone mineral density (BMD) and hip fractures, but the role of plasma DMG in bone health is unknown. METHODS: We studied the associations of plasma DMG with BMD among 5315 participants (46-49 and 71-74 years old) and with hip fracture among 3310 participants (71-74 years old) enrolled in the Hordaland Health Study. RESULTS: In age and sex-adjusted logistic regression models, subjects in the lowest versus highest DMG tertile were more likely to have low BMD (odds ratio [OR] 1.68, 95% confidence interval [CI] 1.43-1.99). The association was stronger in participants exposed compared to those unexposed to nicotine (OR 2.31, 95% CI 1.73-3.07 and OR 1.43, 95% CI 1.16-1.75, respectively, p interaction = 0.008). In the older cohort, Cox regression analyses adjusted for sex showed that low plasma DMG was associated with an increased risk of hip fracture (hazard ratio [HR] 1.70, 95% CI 1.28-2.26). A trend toward an even higher risk was found among women exposed to nicotine (HR 3.41, 95% CI 1.40-8.28). CONCLUSION: Low plasma DMG was associated with low BMD and increased risk of hip fractures. A potential effect modification by nicotine exposure merits particular attention.
UNLABELLED: In the large community-based Hordaland Health Study, low plasma dimethylglycine was associated with low bone mineral density in both middle-aged and elderly subjects and to an increased risk of subsequent hip fracture among the elderly. These associations seemed to be particularly strong among subjects exposed to nicotine. INTRODUCTION:Dimethylglycine (DMG) is a product of the choline oxidation pathway and formed from betaine during the folate-independent remethylation of homocysteine (Hcy) to methionine. Elevated plasma DMG levels are associated with atherosclerotic cardiovascular disease and inflammation, which in turn are related to osteoporosis. High plasma total Hcy and low plasma choline are associated with low bone mineral density (BMD) and hip fractures, but the role of plasma DMG in bone health is unknown. METHODS: We studied the associations of plasma DMG with BMD among 5315 participants (46-49 and 71-74 years old) and with hip fracture among 3310 participants (71-74 years old) enrolled in the Hordaland Health Study. RESULTS: In age and sex-adjusted logistic regression models, subjects in the lowest versus highest DMG tertile were more likely to have low BMD (odds ratio [OR] 1.68, 95% confidence interval [CI] 1.43-1.99). The association was stronger in participants exposed compared to those unexposed to nicotine (OR 2.31, 95% CI 1.73-3.07 and OR 1.43, 95% CI 1.16-1.75, respectively, p interaction = 0.008). In the older cohort, Cox regression analyses adjusted for sex showed that low plasma DMG was associated with an increased risk of hip fracture (hazard ratio [HR] 1.70, 95% CI 1.28-2.26). A trend toward an even higher risk was found among women exposed to nicotine (HR 3.41, 95% CI 1.40-8.28). CONCLUSION: Low plasma DMG was associated with low BMD and increased risk of hip fractures. A potential effect modification by nicotine exposure merits particular attention.
Authors: Oliver Danne; Martin Möckel; Christian Lueders; Clemens Mügge; Gustav A Zschunke; Hans Lufft; Christian Müller; Ulrich Frei Journal: Am J Cardiol Date: 2003-05-01 Impact factor: 2.778
Authors: Yun Kyung Jeon; Jeong Gyu Lee; Sang Soo Kim; Bo Hyun Kim; Seong-Jang Kim; Yong Ki Kim; In Joo Kim Journal: Endocr J Date: 2011 Impact factor: 2.349
Authors: Richard Body; Caroline A Griffith; Brian Keevil; Garry McDowell; Simon Carley; Jamie Ferguson; Kevin Mackway-Jones Journal: Clin Chim Acta Date: 2009-03-31 Impact factor: 3.786
Authors: Astrid K Stunes; Irene Westbroek; Björn I Gustafsson; Reidar Fossmark; Jan H Waarsing; Erik F Eriksen; Christiane Petzold; Janne E Reseland; Unni Syversen Journal: BMC Endocr Disord Date: 2011-05-26 Impact factor: 2.763
Authors: Ahmad M Al-Bashaireh; Linda G Haddad; Michael Weaver; Debra Lynch Kelly; Xing Chengguo; Saunjoo Yoon Journal: J Environ Public Health Date: 2018-07-11
Authors: Xiaoyu Zhang; Hanfei Xu; Gloria Hy Li; Michelle T Long; Ching-Lung Cheung; Ramachandran S Vasan; Yi-Hsiang Hsu; Douglas P Kiel; Ching-Ti Liu Journal: J Bone Miner Res Date: 2021-02-02 Impact factor: 6.741
Authors: Kelsey M Mangano; Sabrina E Noel; Chao-Qiang Lai; Jacob J Christensen; Jose M Ordovas; Bess Dawson-Hughes; Katherine L Tucker; Laurence D Parnell Journal: Bone Date: 2020-12-02 Impact factor: 4.398
Authors: Bozidarka L Zaric; Jelena N Radovanovic; Zoran Gluvic; Alan J Stewart; Magbubah Essack; Olaa Motwalli; Takashi Gojobori; Esma R Isenovic Journal: Front Immunol Date: 2020-09-28 Impact factor: 7.561